Literature DB >> 12902059

Antihyperglycemic effects of three extracts from Momordica charantia.

Jaspreet Virdi1, S Sivakami, S Shahani, A C Suthar, M M Banavalikar, M K Biyani.   

Abstract

Momordica charantia (L.) (Cucurbitaceae) commonly known as bitter gourd or karela is a medicinal plant, used in Ayurveda for treating various diseases, one of which is diabetes mellitus. In this study, various extract powders of the fresh and dried whole fruits were prepared and their blood glucose lowering effect compared by administrating them orally to diabetic rats. The aqueous extract powder of fresh unripe whole fruits at a dose of 20mg/kg body weight was found to reduce fasting blood glucose by 48%, an effect comparable to that of glibenclamide, a known synthetic drug. This extract was tested for nephrotoxicity, hepatotoxicity and biochemical parameters such as SGOT, SGPT and lipid profile. The extract did not show any signs of nephrotoxicity and hepatotoxicity as judged by histological and biochemical parameters. Thus the aqueous extract powder of Momordica charantia, an edible vegetable, appears to be a safe alternative to reducing blood glucose.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902059     DOI: 10.1016/s0378-8741(03)00184-3

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  36 in total

1.  Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats.

Authors:  Umesh C S Yadav; K Moorthy; Najma Z Baquer
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats.

Authors:  Edward O Uche-Nwachi; Carol McEwen
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-10-15

3.  Lipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.

Authors:  Pratibha V Nerurkar; Yun Kyung Lee; Ellen H Linden; Steven Lim; Laurel Pearson; Jennifer Frank; Vivek R Nerurkar
Journal:  Br J Pharmacol       Date:  2006-07-03       Impact factor: 8.739

4.  In vivo Antidiabetic and Antioxidant Potential of Stephania hernandifolia in Streptozotocin-Induced-Diabetic Rats.

Authors:  U Sharma; Rk Sahu; A Roy; Dk Golwala
Journal:  J Young Pharm       Date:  2010-07

Review 5.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

6.  Expression and characterization of Momordica Chanrantia anti-hyperglycaemic peptide in Escherichia coli.

Authors:  Si-Xiu Liu; Zhong-Ping Fu; Rui-Min Mu; Zhi-Bi Hu; Fu-Jun Wang; Xiang-Rong Wang
Journal:  Mol Biol Rep       Date:  2009-07-08       Impact factor: 2.316

Review 7.  Novel nutraceutic therapies for the treatment of metabolic syndrome.

Authors:  Esperanza Martínez-Abundis; Miriam Méndez-Del Villar; Karina G Pérez-Rubio; Laura Y Zuñiga; Marisol Cortez-Navarrete; Alejandra Ramírez-Rodriguez; Manuel González-Ortiz
Journal:  World J Diabetes       Date:  2016-04-10

8.  A case of atrial fibrillation due to Momordica charantia (bitter melon).

Authors:  Ismail Erden; Serkan Ordu; Emine C Erden; Sabri O Caglar
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

9.  Neutraceutical approaches to control diabetes: A natural requisite approach.

Authors:  N Srivastava; G Tiwari; R Tiwari; L K Bhati; Awani K Rai
Journal:  J Nat Sci Biol Med       Date:  2012-07

10.  Evaluation of Antidiabetic Activity and Associated Toxicity of Artemisia afra Aqueous Extract in Wistar Rats.

Authors:  Taofik O Sunmonu; Anthony J Afolayan
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.